Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A prospective, randomized intra-individual study with the sirolimus coated cypher select(TM) and the paclitaxel(TM) coated express balloon expandable stents for the treatment of patients with two de novo native coronary artery lesions.

Next Previous
X
Search
Trial Profile

A prospective, randomized intra-individual study with the sirolimus coated cypher select(TM) and the paclitaxel(TM) coated express balloon expandable stents for the treatment of patients with two de novo native coronary artery lesions.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 03 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Sirolimus (Primary) ; Paclitaxel
  • Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
  • Focus Therapeutic Use
  • Acronyms FRE-RACE

    • Most Recent Events

    • 20 May 2009 Planned number of patients changed from 110 to 112, additional lead trial centre University Hospital Freiburg and lead trial investigator Manfred Zehender as reported by ClinicalTrials.gov.
    • 20 May 2009 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
    • 20 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials. gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top